Why the study?
Does short-term oral anticoagulation reduce coagulation system activation compared to antiplatelet therapy following transcatheter left atrial appendage closure?
Does short-term oral anticoagulation reduce coagulation system activation compared to antiplatelet therapy following transcatheter left atrial appendage closure?
Short-term oral anticoagulation attenuates coagulation system activation post-LAAC compared to antiplatelet therapy, which may reduce the risk of device thrombosis.
Answers are grounded in this paper and cite their sources.
OAC-associated attenuation of post-LAAC coagulation activation supports further study versus APT; should not yet change practice.
OAC (versus APT) was associated with a significant attenuation of coagulation system activation post-LAAC. Spontaneous echocardiography contrast pre-LAAC associated with enhanced coagulation activation post-LAAC, which in turn increased the risk of device thrombosis. These results highlight the urgent need for randomized trials comparing OAC versus APT post-LAAC.
No takes yet. Share an insight, caveat, or question.
Asmarats et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: